Zobrazeno 1 - 10
of 1 340
pro vyhledávání: '"C.C. Hwang"'
Autor:
Carol J. Etzel, Elena Hitraya, Michael E. Weinblatt, Eric H. Sasso, Jeffrey R. Curtis, Nancy A. Shadick, Alexander Gutin, Daniel E. Furst, Xingbin Wang, Merete Lund Hetland, Jerry S. Lanchbury, Darl D. Flake, Mikkel Østergaard, Dimitrios A. Pappas, C.C. Hwang, Yong Gil Hwang, Cecilie Heegaard Brahe, Vibeke Strand
Publikováno v:
Rheumatology (Oxford, England)
Curtis, J R, Flake, D D, Weinblatt, M E, Shadick, N A, Østergaard, M, Hetland, M L, Brahe, C H, Hwang, Y G, Furst, D E, Strand, V, Etzel, C J, Pappas, D A, Wang, X, Hwang, C C, Sasso, E H, Gutin, A, Hitraya, E & Lanchbury, J S 2019, ' Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis ', Rheumatology, vol. 58, no. 5, pp. 874-883 . https://doi.org/10.1093/rheumatology/key367
Curtis, J R, Flake, D D, Weinblatt, M E, Shadick, N A, Østergaard, M, Hetland, M L, Brahe, C H, Hwang, Y G, Furst, D E, Strand, V, Etzel, C J, Pappas, D A, Wang, X, Hwang, C C, Sasso, E H, Gutin, A, Hitraya, E & Lanchbury, J S 2019, ' Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis ', Rheumatology, vol. 58, no. 5, pp. 874-883 . https://doi.org/10.1093/rheumatology/key367
Objective To develop and evaluate an adjusted score for the multi-biomarker disease activity (MBDA) test to account for the effects of age, sex and adiposity in patients with RA. Methods Two models were developed to adjust MBDA score for age, sex and
Autor:
David Chernoff, Xingbin Wang, P. Scott Eastman, Darl D. Flake, Jeffrey R. Curtis, Alan Kivitz, C.C. Hwang
Publikováno v:
Clinical Rheumatology. 38:437-445
The Multi-Biomarker Disease Activity (MBDA) score is a validated rheumatoid arthritis (RA) disease activity measure based on 12 serum biomarkers. Here, we evaluate short-term biological variability of MBDA scores to determine the magnitude of change
Autor:
C.C. Hwang, Jacob M van Laar, Floris P J G Lafeber, Mohsen Elshahaly, Xinyu Liu, Y K Onno Teng, Nadia M T Roodenrijs, Janneke Tekstra, Eric H. Sasso, Maria J. H. de Hair, Gill Wheater
Publikováno v:
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-9 (2018)
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-9 (2018)
Background A multi-biomarker disease activity (MBDA) score has been validated as an objective measure of disease activity in rheumatoid arthritis (RA) and shown to track response to treatment with several disease-modifying anti-rheumatic drugs (DMARD
Autor:
Xinyu Liu, J.M. van Laar, C.C. Hwang, Gillian Wheater, Mohsen Elshahaly, Eric H. Sasso, Janneke Tekstra, Nadia M T Roodenrijs, M. J. H. de Hair, Y K O Teng
Publikováno v:
Rheumatoid arthritis – prognosis, predictors and outcome.
Background A multi-biomarker disease activity (MBDA) score was developed to objectively measure disease activity for patients with rheumatoid arthritis (RA).1 The MBDA score is calculated by an algorithm using concentrations of 12 serum biomarkers. T
Autor:
E. Sasso, Michael E. Weinblatt, C. Heegaard Brahe, Carol J. Etzel, Jerry S. Lanchbury, Nancy A. Shadick, Yong Gil Hwang, M.L. Hetland, Daniel E. Furst, Mikkel Østergaard, Elena Hitraya, Jeffrey R. Curtis, Darl D. Flake, Dimitrios A. Pappas, C.C. Hwang, Alexander Gutin, Vibeke Strand, Xiaoyan Wang
Publikováno v:
Rheumatoid arthritis – prognosis, predictors and outcome.
Background The MBDA score, based on 12 serum proteins, is a validated tool for assessing disease activity in RA patients. MBDA biomarkers may be influenced by age, sex and adiposity. Objectives To develop and validate an adjusted MBDA score that acco
Autor:
C.C. Hwang, Eric H. Sasso, Saedis Saevarsdottir, Oscar G. Segurado, Pierre Geborek, Ingemar F Petersson, Rebecca Bolce, Ronald F van Vollenhoven, Kristina Forslind, K. Hambardzumyan
Publikováno v:
Arthritis & Rheumatology (Hoboken, N.j.)
Arthritis & Rheumatology; 67(11), pp 2855-2860 (2015)
Arthritis & Rheumatology; 67(11), pp 2855-2860 (2015)
Objective Rheumatoid arthritis (RA) clinical trials often exclude patients who have low C‐reactive protein (CRP) levels, which slows enrollment into the trial. The purpose of this study was to determine whether high Multi‐Biomarker Disease Activi
Autor:
Katerina Chatzidionysiou, X Wang, C.C. Hwang, Anca I. Catrina, Aase Haj Hensvold, Saedis Saevarsdottir, Rebecca Bolce, David Chernoff
Publikováno v:
Poster Presentations.
Background The Multi-Biomarker Disease Activity (MBDA) score is a validated tool that quantifies 12 biomarkers to assess disease activity in rheumatoid arthritis (RA) patients. Many studies have demonstrated usefulness of the score for assessing RA d
Publikováno v:
Poster Presentations.
Background The Multi-Biomarker Disease Activity (MBDA) score has been validated as a disease activity metric in rheumatoid arthritis (RA) patients. Patients initiating new therapy or changing therapy frequently have moderate to high MBDA scores. Unde
Publikováno v:
Surface and Coatings Technology. 231:423-427
article i nfo Al-doped ZnO (AZO) nanowires (NWs) were synthesized using low-temperature hydrothermal growth to in- vestigate field emission (FE) characteristics. The intensity ratio of NBE peak to DLE peak (R=INBE/IDLE) in- creases and the half-maxim
Publikováno v:
Solid-State Electronics. 77:72-76
High-performance transparent zinc oxide (ZnO) thin-film transistors (TFTs) with location-controlled lateral-grain growth were fabricated by hydrothermal method. The ZnO active channel was laterally grown with aluminum-doped ZnO (AZO) seed layer under